Morphine
Synonyms / Brand Names: (-)-Heroin hydrochloride, (-)-Morphine, D-(-)-Morphine, Diacetylmorphine hydrochloride, Diamorphine hydrochloride, Heroin hydrochloride, Heroine hydrochloride, Morphine Sulfate, Morphinum, O,O'-Diacetylmorphine hydrochloride, Morphin, Morphina, morphine, Apokyn, Astramorph PF, Avinza, Depodur, Dulcontin, Duramorph PF, Duromorph, Epimorph, Kadian, M-Eslon, M.O.S, MS/L MS/S, MSIR, Meconium, Morfina, Morphia, Morphine Extra-Forte, Morphine Forte, Morphine H.P, Morphinism, Morphitec, Morphium, Moscontin, Ms Contin, Nepenthe, OMS Concentrate, Oramorph SR, Ospalivina, RMS Uniserts, Rescudose, Roxanol, Roxanol 100, Roxanol UD, Statex, Statex Drops, l-Morphine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Dosing and Administration
Intravenous Adult Dosage
The usual dose for administration to adults, via a compatible
Hospira infusion device, is a 1 mg bolus, with a range of 0.2 to 3 mg per incremental dose for the
0.5 mg/mL and 1 mg/mL concentrations and a range of 0.5 to 3 mg per incremental dose for the
5 mg/mL concentration. The recommended Lockout Interval is 6 minutes. The physician may
adjust the dosage either upward or downward;
depending on patient response. Occasionally, it may be necessary to exceed the usual dosage in
cases of exceptionally severe pain or in those patients who become tolerant.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Morphine
Return to top
Publication Resources
Most Recent Articles on Morphine
Review Articles on Morphine
Articles on Morphine in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Morphine
Return to top
Trial Resources
Ongoing Trials with Morphine at Clinical Trials.gov
Trial Results with Morphine
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Morphine
Cochrane Collaboration on Morphine
Cost Effectiveness of Morphine
Return to top
Media Resources
Powerpoint Slides on Morphine
Images of Morphine
Podcasts & MP3s on Morphine
Videos on Morphine
Return to top
Patient Resources
Patient Resources on Morphine
Discussion Groups on Morphine
Patient Handouts on Morphine
Blogs on Morphine
Morphine in the News
Morphine in the Marketplace
Return to top
International Resources
Morphine en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies